In 2018, a study found that the silencing of COL1A2 could inhibit the proliferation, migration, and invasion of gastric cancer through regulating PI3K/AKT signaling pathway, revealing the potency of COL1A2 in HCC (Ao et al., 2018). Here, COL1A2 is linked to hepatocellular carcinoma.